Immunology of aging and immunotherapy of aging-associated diseases

衰老免疫学和衰老相关疾病的免疫治疗

基本信息

  • 批准号:
    10007358
  • 负责人:
  • 金额:
    $ 63.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

We recently reported that aged humans, primates, and mice accumulate a unique type of activated B cells, termed 4BL cells (Lee-Chang et al., Blood, 2014). Contrary to widely believed assumption that innate B cells do not change upon aging, we showed that these cells are derived from innate B1a cells (Lee-Chang et al., J. Immunol., 2016). Mechanistically, aging activates myeloid cells, such as upregulated 4-1BB and CD40L, to convert B1a cells into 4BL cells expressing 4-1BBL, HLA-I, IFNR1, CD86 and membrane TNF. Functionally, this enables 4BL cells to induce expression of granzyme B in CD8+T cells. Here, we explored the mechanism/cause of activation of myeloid cells and their cell subset which convert 4BL cells; and the clinical consequence of the accumulation of 4BL cells in aging. We report that the main cause of aging-associated activation of myeloid cells is gut microbiome. We found that aging changes their composition, such as accumulates potentially pro-inflammatory microbes while decreases beneficial commensal bacteria. Aging gut was markedly decreased in Akkermansia muciniphila, an anaerobic bacterium which protects epithelial integrity of the gut and supports growth of butyrate-producing beneficial commensals. Mechanistically, the loss of A. muciniphila increased leakage of bacterial products such as endotoxin into the circulation and decreased levels of butyrate, an inhibitor of TLR signaling. Thus, the leakage of endotoxin activates CCR2+ monocytes (MO) when butyrate is decreased. Then, activated MO convert innate B1a cells into 4BL cells in the omentum. The clinical consequence of this pathway is that 4BL cells increase hyperglycemia, insulin resistance (IR) in aged hosts via 4-1BBL axis. We show also that this pathway and IR are reversible, as supplementation with A. muciniphila alone or antibiotic enrofloxacin, which increases its abundance, restores normal insulin response in aged mice and macaques. Additionally, treatment with butyrate or antibodies that eliminate CCR2+ MO or 4BL cells have the same effect on IR. These results underscore the previously unknown pathological function of B1a cells, suggesting that the microbiome-MO-4BL cell axis can be targeted to reverse IR and possibly other age-associated pathologies. The results of this study we recently published in high-impact scientific journal (Bodogai et al., Science Transl. Med., 2018). Overall, the project is progressing well as planned. It continues generating novel insights with significant scientific and clinical implications.
我们最近报道,老年人、灵长类动物和小鼠积累了一种独特类型的活化B细胞,称为4 BL细胞(Lee-Chang et al.,Blood,2014)。与普遍认为的先天性B细胞在衰老时不改变的假设相反,我们表明这些细胞来源于先天性B1 a细胞(Lee-Chang et al.,免疫学杂志,2016年)。从机制上讲,衰老激活骨髓细胞,如上调的4-1BB和CD 40 L,将B1 a细胞转化为表达4-1BBL、HLA-I、IFNR 1、CD 86和膜TNF的4 BL细胞。在功能上,这使得4 BL细胞能够诱导颗粒酶B在CD 8 +T细胞中的表达。 在这里,我们探索了骨髓细胞及其转化4 BL细胞的细胞亚群活化的机制/原因;以及衰老中4 BL细胞积累的临床后果。 我们报告说,与衰老相关的骨髓细胞活化的主要原因是肠道微生物组。我们发现,衰老改变了它们的组成,例如积累潜在的促炎微生物,同时减少有益的肠道细菌。嗜粘蛋白阿克曼氏菌(Akkermansia muciniphila)的老化肠道显著减少,这是一种厌氧细菌,可保护肠道上皮完整性并支持产生丁酸盐的有益微生物的生长。机械地,A的损失。嗜粘蛋白菌增加了细菌产物如内毒素向循环中的渗漏,并降低了丁酸盐(TLR信号传导的抑制剂)的水平。因此,当丁酸盐减少时,内毒素的泄漏激活CCR 2+单核细胞(MO)。然后,激活的MO将先天B1 a细胞转化为网膜中的4 BL细胞。 这一通路的临床结果是4 BL细胞通过4-1BBL轴增加老年宿主的高血糖、胰岛素抵抗(IR)。我们还表明,这一途径和IR是可逆的,补充A。单独的嗜粘蛋白体或增加其丰度的抗生素恩诺沙星恢复了老年小鼠和猕猴的正常胰岛素反应。此外,用丁酸盐或消除CCR 2 + MO或4 BL细胞的抗体治疗对IR具有相同的效果。这些结果强调了B1 a细胞先前未知的病理功能,表明微生物组-MO-4 BL细胞轴可以靶向逆转IR和可能的其他年龄相关的病理。这项研究的结果,我们最近发表在高影响力的科学杂志(Bodogai等人,科学翻译医学、2018年)。 总体而言,该项目正在按计划顺利进行。它继续产生具有重大科学和临床意义的新见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Arya Biragyn其他文献

Arya Biragyn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Arya Biragyn', 18)}}的其他基金

Regulatory immune cells in immune suppression: The role of tBregs
调节性免疫细胞在免疫抑制中的作用:tBregs 的作用
  • 批准号:
    8736566
  • 财政年份:
  • 资助金额:
    $ 63.74万
  • 项目类别:
Regulatory immune cells in immune suppression and metastasis
调节免疫细胞在免疫抑制和转移中的作用
  • 批准号:
    8335865
  • 财政年份:
  • 资助金额:
    $ 63.74万
  • 项目类别:
Inflammation and Immunotherapy: Vaccines to treat cancer and Alzheimer's disease
炎症和免疫治疗:治疗癌症和阿尔茨海默病的疫苗
  • 批准号:
    8335927
  • 财政年份:
  • 资助金额:
    $ 63.74万
  • 项目类别:
The role of immunosuppressive cells in metastasis
免疫抑制细胞在转移中的作用
  • 批准号:
    7963976
  • 财政年份:
  • 资助金额:
    $ 63.74万
  • 项目类别:
B cells promote Alzheimers disease via cytolytic CD8+ T cells
B 细胞通过溶细胞 CD8 T 细胞促进阿尔茨海默病
  • 批准号:
    10913115
  • 财政年份:
  • 资助金额:
    $ 63.74万
  • 项目类别:
The role of immune cells in Alzheimer's disease
免疫细胞在阿尔茨海默病中的作用
  • 批准号:
    10012629
  • 财政年份:
  • 资助金额:
    $ 63.74万
  • 项目类别:
Regulatory immune cells in immune suppression: The role of tBregs
调节性免疫细胞在免疫抑制中的作用:tBregs 的作用
  • 批准号:
    8931545
  • 财政年份:
  • 资助金额:
    $ 63.74万
  • 项目类别:
Chemoattractant-based immunotherapeutics to modulate immune and cancer cells
基于化学引诱剂的免疫疗法可调节免疫细胞和癌细胞
  • 批准号:
    7732323
  • 财政年份:
  • 资助金额:
    $ 63.74万
  • 项目类别:
The role of immune cells in Alzheimer's disease
免疫细胞在阿尔茨海默病中的作用
  • 批准号:
    10250898
  • 财政年份:
  • 资助金额:
    $ 63.74万
  • 项目类别:
Development of therapeutic chemokine-based formulations
开发基于趋化因子的治疗制剂
  • 批准号:
    8148261
  • 财政年份:
  • 资助金额:
    $ 63.74万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 63.74万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 63.74万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 63.74万
  • 项目类别:
    Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 63.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 63.74万
  • 项目类别:
    Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 63.74万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 63.74万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 63.74万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 63.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 63.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了